Nightingale Health

Nightingale Health is a health tech company focused on transforming preventive care through innovative blood-testing services. By providing deep health insights, the company enables individuals to understand their disease risk and the impact of lifestyle changes, which are often overlooked in standard lab tests. Its Health Data Platform connects healthcare services with individuals' preventive health needs, empowering them to take proactive measures to maintain their health. This approach not only fuels scientific discoveries and industry advancements but also encourages individuals to adopt healthier lifestyles.

Leena Niemisto Ph.D

Chairman and Board Member

3 past transactions

My Nightingale

Acquisition in 2024
My Nightingale develops and operates pre-symptomatic measures using NMR device to analyse blood components and provide solutions.

Negen Oy

Acquisition in 2022
Negen is a genetic testing and analysis technology company. The company offers genetic tests that are designed to show genetic risks for certain diseases and health problems such as type 2 diabetes and coronary heart disease.

Yolife

Acquisition in 2021
Yolife GmbH, founded in 2017 and based in Berlin, Germany, offers a mobile application focused on enhancing health through lifestyle changes, professional consultations, and medical therapies. The application is available on both the App Store and Google Play. Designed to help individuals add healthy years to their lives, Yolife’s app leverages insights from over 300 scientific studies to provide evidence-based lifestyle suggestions. It features an AI-driven approach that crafts personalized action plans for users, guiding them in fitness, nutrition, and wellness. Users can earn rewards for adhering to recommended diets, which also unlock deals from health-related products and services, thereby promoting overall health and well-being.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.